Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 998.00
-2.00 (-0.20%)
Sep 22, 2026, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 17.26 billion as of September 22, 2026. Its market cap has decreased by -51.82% in one year.
Market Cap
17.26B
Enterprise Value
18.42B
Revenue
4.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
998.00
ChartMarket Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 17.26B, a decrease of -80.87%. That is a compound annual growth rate of -53.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 17.26B | -39.92% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genexine | 131.89B |
| Vaxcell-Bio Therapeutics | 100.24B |
| MedPacto | 93.23B |
| iNtRON Biotechnology | 87.42B |
| ENCell | 73.02B |
| Prestige BioPharma | 71.88B |
| Amicogen | 63.41B |
| ORIENT BIO | 54.13B |